"Doesn't this product actually have a "NEED" and actually quite a large need? drug for glycemia control in patients with type 2 diabetes is Metformin"
bigtuna177, my point is precisely that there are already many versions of metformin available on the US (and Canadian and EU, and every other market).
The original metformin product was introduced in 1958. The patent is long expired, and many generic copies are available - including so-called modified release versions that will do exactly the same thing that it is claimed Met4 will do (that claim being made without the benefit of any human studies, and therefore without any proof that would satisy any regulatory agency anywhere in the world, let alone the FDA or EMA).
I say this to anybody considering investing or even trading in the biopharmaceutical penny stocks (or Big Board Pharma stocks for that matter:
If you don't understand the basics of pharmacology, the marketplace for pharmaceuticals or the regulatory process in the US and elsewhere, then you're going to get hosed by criminal enterprises who would just love to take your money.
Simple as that - and that's what the crooks behind the promotion of evidently fraudulent Spencer Pharmaceuticals are counting on.
News 
Market Data 
Discover 
AI
